Tristel PLC
Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a TSNLF research report →
About the company
Operating both within the United Kingdom and globally, Tristel plc specializes in the development, production, and distribution of products designed for infection control. Its business is structured into three primary divisions: Hospital Medical Device Decontamination, Hospital Environmental Surface Disinfection, and a third, unnamed 'Other' segment. Under its proprietary Tristel brand, the firm provides a comprehensive range of medical instrument disinfection solutions.
- CEO
- Matthew Giovanni Sassone
- IPO
- 2014
- Employees
- 233
- HQ
- Snailwell, GB
Price Chart
- Market Cap
- $265.43M
- P/E
- 24.27
- P/S
- 3.88
- P/B
- 5.69
- EV/EBITDA
- 15.24
- Div Yield
- 3.55%
- Gross Margin
- 78.65%
- Op Margin
- 19.72%
- Net Margin
- 15.88%
- ROE
- 23.64%
- ROIC
- 19.70%
- Revenue
- $46.46M · 10.80%
- Net Income
- $6.64M · 2.33%
- EPS
- $0.14 · 0.00%
- Op Income
- $8.40M
- FCF YoY
- 8.67%
- 52W High
- $6.00
- 52W Low
- $5.00
- 50D MA
- $5.48
- 200D MA
- $5.41
- Beta
- 0.34
- Avg Volume
- 51
Get TickerSpark's AI analysis on TSNLF
Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →Already have an account? Log in
Our TSNLF coverage
Recent articles, reports, and earnings notes.
No research on TSNLF yet
For a full analyst-grade research report — grades, price targets, financials, chart analysis — generate one on demand.
Generate TSNLF report →Similar companies
Peers in the same neighborhood.